Document is current
Any future updates will be listed below
-
Authors
Maqhuzu, Phillen Nozibuyiso
Bocuk, Derya
Boelz, Sebastian
Hosseini, Sabrina Khageh
Leeb, Christian
Renevey, Francois
Mevius, Antje
Greth, Katja
Christofyllakis, Konstantinos
- License Information
-
More Information
Article History
Received: 14 April 2025
Accepted: 14 August 2025
First Online: 29 September 2025
Declarations
:
: Ethical approval for this study was not required since it was based on anonymised claims data.
: PM, DB, SB, SH, CL and FR are employees of Eli Lilly. DB is a minor shareholder of Eli Lilly. AM and KG declare no competing interests. KC has received educational and/or travel grants and/or research funding from AbbVie, AstraZeneca, Beigene, Celgene, Grifols, Jazz Pharmaceuticals, Hexal, Lilly and Novartis. KC has received honoraria from AstraZeneca, Takeda and Roche. KC has participated in advisory boards and/or speaker bureaus for AstraZeneca, Beigene, BMS, Janssen, Kite/Gilead, Novartis, Takeda and Sobi.
